Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Defective Drugs
Parker Waichman Nursing Home Abuse Mobile App

Get our Defective Drugs app for iOS and Android devices.

Your Personal Injury Lawyer - Parker Waichman LLP Android app on Google Play

Just Because a Doctor Prescribes a Drug Doesn’t Mean It’s not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Just Because a Doctor Prescribes a Drug Doesn't Mean It's not Dangerous or Defective

Today, the pharmaceutical industry is producing drugs aimed at just about every ailment known to man, adding years to nearly everyone’s life, if not outright saving them. They also enable us to live a better-quality lifestyle for a much longer period of time.

Regrettably, some of the drugs these companies manufacture can ultimately prove to be defective, as well as dangerous – and even deadly. Sometimes it may take years for the side effects to even emerge – which means that ultimately some drugs on the market may end up doing more harm than good.

Like any other for-profit corporate entity, pharmaceutical companies are motivated, in varying degrees, by profit. Sometimes profits are more important than people. Anyone who reads the newspaper knows this to be a fact. In many a lawsuit, a pharmaceutical company will be charged with having known full well about some harmful side effect tied to its flagship billion-dollar powerhouse drug – in some instances, many years in advance of this fact’s public disclosure. Companies hide clinical evidence that a drug may be defective in order to gain the U.S. Food and Drug Administration (FDA)’s approval, and to not create obstacles to sales.

Prescription drugs with deadly or dangerous side effects are sometimes rushed to market without adequate testing, and often people are injured or die before the FDA can identify these drugs as having dangerous side effects that can far outweigh whatever benefits the marketing group had touted.

When an FDA classification leads to a drug recall and when an injury occurs, a lawsuit is frequently filed; drug recall lawsuits typically fall into a range of categories, including drug injury, product liability or medical malpractice lawsuits against drug companies.

If you or a loved one have been injured as a result of a prescription drug, you may have valuable legal rights. Parker Waichman LLP urges you to contact us by completing the form at right or call us at 1-800-YOURLAWYER (1-800-968-7529).

To view more information involving a specific defective drug, drug recall, or drug lawsuit, please click on one of the links listed below.

If the defective drug you are looking for is not below, please visit our Defective Drugs Archives page for additional articles about defective drug lawsuits that Parker Waichman LLP has defended for our clients.

To view defective drug videos from our attorneys Click Here.


Defective Drugs

Defective Drugs NewsRSS Feed

Canadian Health Regulatory Agency Issues New Safety Information for Multiple Sclerosis Drug Gilenya

Oct 1, 2015
Health Canada, the Canadian health regulatory agency, has updated the drug label for the multiple sclerosis drug Gilenya (fingolimod) to include new...

FDA Expert Panel Recommends Label Changes Better Guidance for Essure Birth Control Device

Sep 29, 2015
After collecting evidence from scientists and clinicians and hearing accounts from affected women, a Food and Drug Administration (FDA) advisory...

FDA Safety Announcement Warns of Increased Bone Fracture Risk for Diabetes Drug Invokana

Sep 25, 2015
The Food and Drug Administration (FDA) has issued a new safety announcement warning of increased risk of bone fractures and reduced bone mineral...

Researchers Say FDA Should be Cautious in Using "Breakthrough" to Describe New Drugs

Sep 24, 2015
Researchers argue that the U.S. Food and Drug Administration (FDA) should avoid using words like "breakthrough" and "promising" when making...

FDA Orders Revised Label for Antibacterial Combination Drug Avycaz to Prevent Dosing Errors

Sep 23, 2015
The Food and Drug Administration (FDA) has issued a drug safety communication warning of the risk of dosing errors with the intravenous antibacterial...

Increased Risk of Atypical Hip Fractures Associated with Bisphosphonate Use

Sep 23, 2015
Women with osteoporosis who take bisphosphonate drugs to prevent fractures have an increased risk of atypical hip fractures, new research...

Ayurvedic Dietary Supplements Recalled Because of Dangerous Levels of Lead and Mercury

Sep 21, 2015
Eleven Ayurvedic dietary supplements have been recalled because they were found to contain elevated lead and mercury levels. The elevated lead and...

FDA Updates Requirements for Clozapine in Light of Neutropenia Risk

Sep 16, 2015
The U.S. Food and Drug Administration (FDA) is changing certain safety requirements for clozapine, a medication used to treat patients with...

Patients Taking Invokana and Invokamet Face Increased Risk

Sep 15, 2015
Diabetes patients taking the drugs Invokana and Invokamet (canagliflozin) face increased bone fracture risk, the Food and Drug Administration (FDA)...

Class I Recall Issued for OmniPod Insulin Management System

Sep 14, 2015
The OminPod Insulin Management System manufactured by Insulet Corporation has been recalled because it may fail to deliver insulin, an announcement...

The Two Dominant Classes of Diabetes Drugs Are under Recent FDA Warnings

Sep 11, 2015
The Centers for Disease Control and Prevention (CDC) calculates that 29.1 million Americans (9.3 percent of the population) have diabetes, creating a...

Europe Bans 700 Generic Medicines Because of Flawed Clinical Tests But FDA Allows Them to Remain on Market in U.S.

Sep 1, 2015
The U.S. Food and Drug Administration (FDA) has found no systemic issues affecting the safety or efficacy of generic drugs tested at GVK BioSciences,...
Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo